BeStock  
Stocks › Biotechnology › TRAX

First Tracks Biotherapeutics TRAX

US equityMarket cap rank #2772Biotechnology
$41.64 −$2.82 (-6.34%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $40.70 -2.26%
Open$43.99
Prev close$44.46
Day range$41.23 – $44.74
Volume504.4K
Market cap$1.75B
P/E (TTM)–
Dividend yield–

TRAX Stock News

Headlines matching First Tracks Biotherapeutics or the TRAX ticker, most recent first.

  • CCORF Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $50Market news · 30 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $57Market news · 3 Sep 2026 · Direct mention
  • Barclays Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $65Market news · 3 Sep 2026 · Direct mention
  • Wedbush Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Raises Target Price to $70 PositiveMarket news · 3 Sep 2026 · Direct mention
  • Evercore Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $65Market news · 18 Sep 2026 · Direct mention
  • Guggenheim Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $100Market news · 17 Sep 2026 · Direct mention
  • Piper Sandler Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $95Market news · 27 Aug 2026 · Direct mention
  • Analysts Offer Insights on NA Companies: Arcturus Therapeutics (ARCT), EquipmentShare.com, Inc. (EQPT) and First Tracks Biotherapeutics Inc (TRAX)TipRanks · 20 Aug 2026 · Direct mention
  • J.P. Morgan Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Raises Target Price to $65 PositiveMarket news · 20 Aug 2026 · Direct mention
  • UBS Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $65Market news · 14 Aug 2026 · Direct mention
  • Analysts Offer Insights on NA Companies: Cerebras Systems, Inc. Class A (CBRS), CitroTech (CITR) and First Tracks Biotherapeutics Inc (TRAX)TipRanks · 13 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for First Tracks Biotherapeutics(TRAX.US), With a Forecast Between $57 to $95Market news · 13 Aug 2026 · Direct mention
  • Analysts Offer Insights on NA Companies: First Tracks Biotherapeutics Inc (TRAX), BETA Technologies, Inc. Class A (BETA) and Cerebras Systems, Inc. Class A (CBRS)TipRanks · 13 Aug 2026 · Direct mention
  • UBS Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $65Market news · 10 Aug 2026 · Direct mention
  • Wedbush Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Raises Target Price to $60 PositiveMarket news · 28 Jul 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on TRAX.

Sign in to join the discussion.

Scroll to Top